← Back to Search

Behavioral Intervention

Ultrabrief Behavioral Activation for Reducing Alcohol Use (UBA Trial)

N/A
Waitlist Available
Led By Stacy Daughters, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of the study, an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new, single-session treatment for people with mild to moderate alcohol use disorder to see if it is feasible, acceptable, and effective.

Eligible Conditions
  • Alcoholism
  • Alcohol Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of the study, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of the study, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability via summary scores and statistics of study-designed treatment engagement and acceptability assessment instruments
Feasibility via average rate of enrollment of eligible participants
Feasibility via computed fraction of participants who have completed all assessment in this study
Secondary study objectives
Change in alcohol consumption via average amount of alcohol consumed per drinking day
Change in alcohol consumption via number of drinking days
Feasibility via computed fraction of participants that successfully completed at least 1 of each activity independently as per record in treatment booklet
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: UBA ArmExperimental Treatment1 Intervention
All subjects in this arm will receive ultrabrief behavioral activation therapy via a single, 90-minute session.
Group II: Control ArmActive Control1 Intervention
All subjects in this arm will complete all study assessment instruments collected in the interventional arm but will not receive an intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrabrief Behavioral Activation
2022
N/A
~40

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,569 Previous Clinical Trials
4,319,544 Total Patients Enrolled
Stacy Daughters, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
~11 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top